CLPBY
Price
$11.09
Change
+$0.21 (+1.93%)
Updated
Dec 20 closing price
43 days until earnings call
WILLF
Price
$35.75
Change
-$0.49 (-1.35%)
Updated
Dec 19 closing price
Ad is loading...

CLPBY vs WILLF

Header iconCLPBY vs WILLF Comparison
Open Charts CLPBY vs WILLFBanner chart's image
Coloplast AS
Price$11.09
Change+$0.21 (+1.93%)
Volume$248.46K
CapitalizationN/A
Demant AS
Price$35.75
Change-$0.49 (-1.35%)
Volume$202
CapitalizationN/A
CLPBY vs WILLF Comparison Chart
Loading...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBY vs. WILLF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBY is a Hold and WILLF is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (CLPBY: $11.09 vs. WILLF: $35.75)
Brand notoriety: CLPBY and WILLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPBY: 191% vs. WILLF: 40%
Market capitalization -- CLPBY: $26.46B vs. WILLF: $8.95B
CLPBY [@Medical Specialties] is valued at $26.46B. WILLF’s [@Medical Specialties] market capitalization is $8.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBY’s FA Score shows that 2 FA rating(s) are green whileWILLF’s FA Score has 0 green FA rating(s).

  • CLPBY’s FA Score: 2 green, 3 red.
  • WILLF’s FA Score: 0 green, 5 red.
According to our system of comparison, CLPBY is a better buy in the long-term than WILLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBY’s TA Score shows that 3 TA indicator(s) are bullish.

  • CLPBY’s TA Score: 3 bullish, 5 bearish.

Price Growth

CLPBY (@Medical Specialties) experienced а -5.05% price change this week, while WILLF (@Medical Specialties) price change was -1.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.46%. For the same industry, the average monthly price growth was -0.49%, and the average quarterly price growth was +1.96%.

Reported Earning Dates

CLPBY is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Medical Specialties (-1.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBY($26.5B) has a higher market cap than WILLF($8.95B). CLPBY has higher P/E ratio than WILLF: CLPBY (36.50) vs WILLF (25.84). CLPBY YTD gains are higher at: 0.712 vs. WILLF (-18.750). CLPBY has higher annual earnings (EBITDA): 7.65B vs. WILLF (4.3B). CLPBY has higher revenues than WILLF: CLPBY (24.1B) vs WILLF (19.7B).
CLPBYWILLFCLPBY / WILLF
Capitalization26.5B8.95B296%
EBITDA7.65B4.3B178%
Gain YTD0.712-18.750-4%
P/E Ratio36.5025.84141%
Revenue24.1B19.7B122%
Total CashN/A1.13B-
Total DebtN/A15.1B-
FUNDAMENTALS RATINGS
CLPBY vs WILLF: Fundamental Ratings
CLPBY
WILLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
8572
SMR RATING
1..100
3396
PRICE GROWTH RATING
1..100
6177
P/E GROWTH RATING
1..100
7685
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBY's Valuation (7) in the null industry is somewhat better than the same rating for WILLF (68). This means that CLPBY’s stock grew somewhat faster than WILLF’s over the last 12 months.

WILLF's Profit vs Risk Rating (72) in the null industry is in the same range as CLPBY (85). This means that WILLF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBY's SMR Rating (33) in the null industry is somewhat better than the same rating for WILLF (96). This means that CLPBY’s stock grew somewhat faster than WILLF’s over the last 12 months.

CLPBY's Price Growth Rating (61) in the null industry is in the same range as WILLF (77). This means that CLPBY’s stock grew similarly to WILLF’s over the last 12 months.

CLPBY's P/E Growth Rating (76) in the null industry is in the same range as WILLF (85). This means that CLPBY’s stock grew similarly to WILLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBY
RSI
ODDS (%)
Bullish Trend 4 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bearish Trend 4 days ago
50%
MACD
ODDS (%)
Bearish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
57%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
62%
Aroon
ODDS (%)
Bearish Trend 4 days ago
67%
View a ticker or compare two or three
Ad is loading...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X95104.940000-2119.789000
-2.18%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with SMMNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
+1.93%
SMMNY - CLPBY
35%
Loosely correlated
+0.11%
SAUHY - CLPBY
35%
Loosely correlated
+1.91%
ESLOY - CLPBY
32%
Poorly correlated
-0.12%
WILLF - CLPBY
23%
Poorly correlated
N/A
AMBBY - CLPBY
23%
Poorly correlated
N/A
More

WILLF and

Correlation & Price change

A.I.dvisor tells us that WILLF and MEDP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WILLF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WILLF
1D Price
Change %
WILLF100%
N/A
MEDP - WILLF
24%
Poorly correlated
+0.64%
CLPBY - WILLF
23%
Poorly correlated
+1.93%
VERO - WILLF
23%
Poorly correlated
+1.83%
ICLR - WILLF
20%
Poorly correlated
+1.42%
WILYY - WILLF
14%
Poorly correlated
N/A
More